cholangitis bpc 157 Primary biliary cirrhosis Protective Effects of BPC 157

The AUGUSTUS trial (N=4,614) showed that adding aspirin to apixaban in patients with atrial fibrillation and recent acute coronary syndrome increased bleeding events from 7.3% to 10.9% over 6 months (HR 1.89 to 95% CI 1.59 to 2.24) [12]

In other words: Was the immune system in these children making an antibody that could prevent folate in the bloodstream from reaching the brain

Some peptides induce antibody formation which can decrease effectiveness or infrequently cause hypersensitivity

The other form, 5-deoxyadenosylcobalamin, is a cofactor needed by the enzyme that converts L-methylmalonyl-CoA to succinyl-CoA